BigHat Biosciences closes $75M Series C led by DFJ Growth and Premji Invest to advance AI-driven biotech pipeline.
Amount Raised
$75 Million
Round Type
Series C
San MateoBiotechnologyInvestors
Description
BigHat Biosciences, a California-based clinical-stage AI-driven biotech company, announced the completion of a $75 million Series C financing round. The round was co-led by DFJ Growth and Premji Invest, with participation from Catalio Capital Management, LG Technology Ventures, and Sigmas Group. Existing investors including 8VC, Alexandria Venture Investments, Amgen, Andreessen Horowitz, Discovery Ventures, GRIDS Capital, Intermountain Ventures, Eli Lilly, Merck Global Health Innovation Fund, Quadrille Capital, and Section 32 also participated. The funding brings BigHat's total capital raised to date to $223 million.
Quick answer
BigHat Biosciences raised $75 Million in a Series C round, dated September 24, 2026. Investors: Eli Lilly, Alexandria Venture Investments, Amgen, Andreessen Horowitz, 8 Vc, Discovery Ventures, 8 VC and Grids Capital. BigHat Biosciences is based in San Mateo, California, United States.
- How much did BigHat Biosciences raise?
- BigHat Biosciences raised $75 Million in a Series C round on September 24, 2026.
- Who invested in BigHat Biosciences?
- Eli Lilly, Alexandria Venture Investments, Amgen, Andreessen Horowitz, 8 Vc, Discovery Ventures, 8 VC and Grids Capital are named as investors in this round.
- What does BigHat Biosciences do?
- BigHat’s mission is to improve human health by making it far easier to design advanced, next-generation antibody therapeutics.
- Where is BigHat Biosciences based and how big is it?
- BigHat Biosciences is based in San Mateo, California, United States. Fundz records about 111 employees.
- Who are the decision-makers at BigHat Biosciences?
- Fundz holds 2 contacts at BigHat Biosciences, including the Senior Director, BD & Strategy. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as BigHat Biosciences that raised within 45 days of this round, from Fundz verified event records.
- BioVie raised $4.7M (Post-IPO Equity) on November 6, 2026.
- Alethio raised $90M (Series A) on November 5, 2026.
- altM raised $10M (Series A) on November 5, 2026.
- FluoRok raised $30M (Series A) on November 5, 2026.
- T-Therapeutics raised $133M (Series B) on November 5, 2026.
- Venomics AI raised $2.7M (Pre-Seed) on November 5, 2026.
Who to call at BigHat Biosciences, and when
A new round usually means BigHat Biosciences is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day BigHat Biosciences raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at BigHat Biosciences, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at BigHat Biosciences. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment BigHat Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
BigHat Biosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.